Severe Acute Respiratory Syndrome Coronaviruses with Mutations in the E Protein Are Attenuated and Promising Vaccine Candidates

Severe acute respiratory syndrome coronavirus (SARS-CoV) causes a respiratory disease with a mortality rate of 10%. A mouse-adapted SARS-CoV (SARS-CoV-MA15) lacking the envelope (E) protein (rSARS-CoV-MA15-ΔE) is attenuated in vivo. To identify E protein regions and host responses that contribute to...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Virol
Egile Nagusiak: Regla-Nava, Jose A., Nieto-Torres, Jose L., Jimenez-Guardeño, Jose M., Fernandez-Delgado, Raul, Fett, Craig, Castaño-Rodríguez, Carlos, Perlman, Stanley, Enjuanes, Luis, DeDiego, Marta L.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2015
Gaiak:
Vaccines and Antiviral Agents
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4403406/
https://ncbi.nlm.nih.gov/pubmed/25609816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.03566-14
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak